Novel orphan nuclear receptor-coregulator interactions controlling anti-cancer drug metabolism

Current Drug Metabolism

Volumn 9, Issue 7, 2008, Pages 611-613

  Gollamudi, Radharani ^a   Gupta, Divya ^a   Goel, Sanjay ^a   Mani, Sridhar ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer chemotherapy; Coregulators; Histone acetylation; Nuclear receptors; Pregnenolone X receptor

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; 4 HYDROXYTAMOXIFEN; ANTINEOPLASTIC AGENT; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYCLOPHOSPHAMIDE; DISCODERMOLIDE; DOCETAXEL; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE DEACETYLASE; IFOSFAMIDE; IXABEPILONE; KETOCONAZOLE; NUCLEAR RECEPTOR COREPRESSOR; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GLUCOCORTICOID RECEPTOR COACTIVATOR 1; PHENOBARBITAL; PREGNANE X RECEPTOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN; TRABECTEDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG; VINBLASTINE;

BIOTRANSFORMATION; DRUG CLEARANCE; DRUG METABOLISM; DRUG SENSITIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS;

EID: 52449095533     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008785821701     Document Type: Review

References (44)

1. Mani, S.; Huang, H.; Sundarababu, S.; Liu, W.; Kalpana, G.; Smith, A.B. and Horwitz, S.B. (2005) Clin. Cancer Res., 11(17), 6359-69.
2. Orans, J.; Teotico, D.G. and Redinbo, M.R. (2005) Mol. Endocrinol., 19(12), 2891-900.
3. Bhalla, S.; Ozalp, C.; Fang, S.; Xiang, L. and Kemper, J.K. (2004) J. Biol. Chem., 279(43), 45139-47.
4. Li, T. and Chiang, J.Y. Drug. Metab. Dispos., (2006) 34(5):756-64.
5. Ourlin, J.C.; Lasserre, F.; Pineau, T.; Fabre, J.M.; Sa-Cunha, A.; Maurel, P.; Vilarem, M.J. and Pascussi, J.M. (2003) Mol. Endocrinol., 17(9), 1693-703.
6. Tirona, R.G.; Lee, W.; Leake, B.F.; Lan, L.B.; Cline, C.B.; Lamba, V.; Parviz, F.; Duncan, S.A.; Inoue, Y.; Schuetz, E.G. and Kim, R.B. (2003) Nat. Med., 9(2), 220-4.
7. Jover, R.; Bort, R.; Gomez-Lechon, M.J. and Castell, J.V. (2001) Hepatology, 33(3),668-75
8. Miki, Y.; Suzuki, T.; Tazawa, C.; Blumberg, B. and Sasano, H. (2005) Mol. Cell. Endocrinol., 231(1-2),75-85.
9. Francis, G.A.; Fayard, E.; Picard, E. and Auwerx, J. (2003) Ann. Rev. Physiol., 65, 261-311.
10. Chawla, A.; Repam, J.J.; Evans, R.M. and Mangelsdorf, D.J. (2001) Science, 94(5548),1866-70.
11. Ordentlich, P.; Downes, M. and Evans, R.M. (2001) Curr. Top. Microbiol. Immunol., 254,101-16.
12. Privalsky, M.L. (2004) Annu. Rev. Physiol., 66, 315-60.
13. Hu, X. and Lazar, M.A. (1999) Nature, 402(6757), 93-6.
14. Nagy, L.; Kao, H.Y.; Love, J.D.; Li, C.; Banayo, E.; Gooch, J.T.; Krishna, V.; Evans, R.M. and Schwabe, J.W. (1999) Genes Dev., 13(24), 3209-16.
15. Codina, A.; Love, J.D.; Li, Y.; Lazar, M.A.; Neuhaus, D. and Schwabe JW. (2005) Proc. Natl. Acad. Sci. USA, 102(17),6009-14.
16. Chen, Y.; Kissling, G.; Negishi, M. and Goldstein, J.A. (2005) J. Pharmacol. Exp. Ther., 314(3), 1125-33.
17. Pascussi, J.M. and Vilarem, M.J. (2005) Med. Sci. (Paris), 21(6-7), 582-3.
18. Xu, Y.; Hashizume, T.; Shuhart, M.C.; Davis CL, Nelson, W.L.; Sakaki, T.; Kalhorn, T.F.; Watkins, P.B. and Schuetz, E.G. (2006) Mol. Pharmacol., 69(1), 56-65.
19. Pascussi, J.M.; Robert, A.; Nguyen, M.; Walrant-Debray, O.; Garabedian, M.; Martin, P.; Pineau, T.; Maurel, P. and Vilarem, M.J. (2005) J. Clin. Invest., 115(1), 177-86.
20. Peter, I.; Shearman, A.M.; Zucker, D.R.; Schmid, C.H.; Demissie, S.; Cupples, Mendelsohn, M.E.; Housman, D.E. and Levy, D. (2005) J. Hypertens., 23(12), 2193-200.
21. Patel, M.S.; Cole, D.E.; Smith, J.D.; Hawker, G.A.; Wong, B.; Trang, H.; Vieth, R.; Meltzer, P. and Rubin, L.A. (2000) J. Bone Miner. Res., 15(11),2231-9.
22. Zannis, V.I.; Liu, T.; Zanni, M.; Kan, H.Y. and Kardassis, D. (2003) Clin. Chem. Lab. Med., 41(4), 411-24.
23. Vimaleswaran, K.S.; Radha, V.; Ghosh, S.; Majumder, P.P.; Deepa, R.; Babu, H.N.; Rao, M.R. and Mohan, V. (2005) Diabet. Med., 22(11), 1516-21.
24. Hung, C.C.; Farooqi, I.S.; Ong, K.; Luan, J.; Keogh, J.M.; Pembrey, M.; Yeo, G.S.; Dunger, D.; Wareham, N.J. and O'Rahilly, S. (2003) Diabetes, 52(5), 1288-91.
25. Esterbauer, H.; Oberkofler, H.; Linnemayr, V.; Iglseder, B.; Hedegger, M.; Fastner, G.; Krempler, F. and Patsch, W. (2002) Diabetes, 51(4), 1281-6.
26. Hara, K.; Tobe, K.; Okada, T.; Kadowaki, H.; Akanuma, Y.; Ito, C.; Kimura, S. and Kadowaki, T. (2002) Diabetologia, 45(5), 740-3.
27. Ikeda, S.; Kurose, K.; Jinno, H.; Sai, K.; Ozawa, S.; Hasegawa R. and Sawada, J. (2005) Mol. Genet. Metab., 86(1-2), 314-9.
28. Miao, J.; Fang, S.; Bae, Y. and Kemper, J.K. (2006) J. Biol. Chem., 281(21), 14537-46.
29. Costa, R.H.; Kalinichenko, V.V.; Tan, Y. and Wang, I.C. (2005) Hepatology, 42(5), 1004-8.
30. Faucette, S.R.; Sueyoshi, T.; Smith, C.M.; Negishi, M.; Lecluyse, E.L. and Wang, H. (2006) J. Pharmacol. Exp. Ther., 317(3): 1200-9.
31. Suino, K.; Peng, L.; Reynolds, R.; Li, Y.; Cha, J.Y. Repa, J.J.; Kliewer, S.A. and Xu, H.E. (2004) Mol. Cell., 16(6), 893-905.
32. Synold, T.W.; Dussault, I. and Forman BM. (2001) Nat. Med., 7(5), 584-90.
33. Nallani, S.C.; Goodwin, B.; Maglich. J.M.; Buckley, D.J.; Buckley, A.R. and Desai, P.B. (2003) Drug Metab. Dispos., 31(5), 681-4.
34. Kostrubsky, V.E.; Ramachandran, V.; Venkataramanan, R.; Dorko, K.; Esplen, J.E. and Zhang, S. (1999) Drug Metab. Dispos., 27(8), 887-94.
35. Kostrubsky, V.E.; Lewis, L.D.; Strom, S.C.; Wood, S.G.; Schuetz, E.G.; Schuetz, J.D. Sinclair, PR; Wrighton, S.A. and Sinclair, J.F. (1998) Arch. Biochem. Biophys., 355(2), 131-6.
36. Harmsen, S.; Meijerman, I.; Beijnen, J.H. and Schellens, J.H.M. (2007) Cancer Treat. Rev., 33(4), 369-80.
37. Chang, T.K.; Thomas, K.H.; Waxman, D.J. and David, J. (2006) Drug Metab. Rev., 38(1), 51-73.
38. Lai-San, T.; Nicholas, H.G.; Holford.; Sok-Ying, Hor.; Theresa, T.; Lingzhi, W.; Rui-Chen, L.; How-Sung, L.; Soo-Chin, L. and Boon-Cher, G. (2007) Clin. Cancer Res., 13(23).
39. Desai, P.B.; Nallani, S.C.; Sane, R.S.; Moore, L.B.; Goodwin, B.J.; Buckley, D.J. (2002) Drug Metab. Dispos., 30(5), 608-12.
40. Lindley, C.; Hamilton, G.; McCune, J.S.; Faucette, S.; Shord, S.S. and Hawke, R.L. (2002) Drug Metab. Dispos., 30(7), 814-22.
41. Yakun, C.; Yong, T.; Man-Tzu, W.; Su, Z. and Daotai, N. (2007) Cancer Res., 67(21), 10361-10367
42. Mensah-Osman, E.; Lin, H.; Reinke, D.; Hollenberg, P. and Baker, L. (2005) ASCO Annual Meeting, Abstract No. 9026.
43. Huang, H.; Wang, H.; Sinz, M.; Zoeckler, M.; Staudinger, J. and Redinbo, M.R. (2007) Oncogene, 26(2), 258-68.
44. Hongwei, W.; Haiyan, H.; Hao, L.; Denise, G.; Teotico.; Michael, S.; Sharyn, D.; Baker.; Jeffrey, S.; Ganjam, K.; Matthew, R.; Redinbo, ??. and Sridhar, M. (2007) Clin. Cancer Res., 13(8), 2489.